Pharmaceutical and cosmetic uses of fibrous clays

Developments in Clay Science

Volumn 3, Issue , 2011, Pages 299-324

  López Galindo, Alberto ^a   Viseras, César ^a,b   Aguzzi, Carola ^b   Cerezo, Pilar ^b  

^a INSTITUTO ANDALUZ DE CIENCIAS DE LA TIERRA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879409068     PISSN: 15724352     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53607-5.00013-X     Document Type: Chapter

References (172)

1. Adamis, Z., Williams, R.B., 2005. Bentonite, Kaolin, and Selected Clay Minerals. Environmental Health Criteria, 231. World Health Organization Library, Cataloguing-in-Publication Data, Geneva.
2. Aggag, M.E., Elkhouly, A.E., Fawzy, M.A., Aboulmagd, E., 2004. Influence of some pharmaceutical substances and dosage forms on the antibacterial activity and bioavailability of ofloxacin, pefloxacin and norfloxacin. Alex. J. Pharm. Sci. 18 (2), 101-108.
3. Aguzzi, C., Cerezo, P., Viseras, C., Caramella, C., 2007. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 36, 22-36.
4. Al-Gohary, O.M.N., 1990. The effect of drugs on the in vitro acid-reactivity of magnesium trisilicate. Acta Pharm. Technol. 36 (4), 254-258.
5. Al-Gohary, O.M.N., 1991. An in vitro study of the interaction between mebeverine hydrochloride and magnesium trisilicate powder. Int. J. Pharm. 67 (1), 89-95.
6. Al-Gohary, O.M.N., Lyall, J., Murray, J.B., 1987. Adsorption of antihypertensives by suspensoids. Part. 1. Adsorption of propanolol hydrochloride by attapulgite, charcoal, kaolin and magnesium trisilicate. Pharm. Acta. Helv. 62 (3), 66-72.
7. Anonymous, 1998. The silicates: attapulgite, kaolin, kieselguhr, magnesium trisilicate, pumice, talc. Int. J. Pharm. Comp. 2 (2), 162-163.
8. Anonymous, 2003. Annual review of cosmetic ingredient safety assessments-2001/2002. Int. J. Toxicol. 22 (Suppl. 1), 1-35.
9. Arayne, M.S., Sultana, N., 1993. Erythromycin-antacid interaction. Pharmazie 48, 599-602.
10. Arayne, M.S., Sultana, N., Zaman, M.K., 2003. In vitro availability of gliclazide in presence of antacids. Pak. J. Pharm. Sci. 16 (1), 35-49.
11. Arayne, M.S., Sultana, N., Kamran, Z., Rana, M., 2004. In vitro availability of glibenclamide in presence of antacids. Pak. J. Pharm. Sci. 17 (2), 41-56.
12. Arayne, M.S., Sultana, N., Hussain, F., 2005. Interactions between ciprofloxacin and antacids-dissolution and adsorption studies. Drug Metab. Drug Interact. 21 (2), 117-129.
13. Auzerie, J., 1999. Pharmaceutical composition containing rehydration solution, antiseptic, prebiotic, and modifier of intestinal transit for the treatment of acute gastro-enteritis. Patent number: FR 2770778, 18 pp.
14. Babhair, S.A., Tariq, M., 1983. Effect of magnesium trisilicate and kaolin-pectin on the bioavailability of trimethoprim. Res. Commun. Chem. Pathol. Pharm. 40 (1), 165-168.
15. Bajdik, J., Korbely, A., Pintye-Hodi, K., 2009. Formulation of intelligent tablets with an antacid effect. Pharm. Dev. Technol. 14 (5), 471-475.
16. Baris, Y.I., Sahin, A.A., Erkan, M.L., 1980. Clinical and radiological study in sepiolite workers. Arch. Environ. Health 35, 343-346.
17. Be'gin, R., Masse', S., Rola-Pleszcynski, M., Geoffroy, M., Martel, M., Desmarais, Y., et al., 1987. The lung biological activity of American attapulgite. Environ. Res. 42, 328-339.
18. Bellmann, B., Muhle, H., Ernst, H., 1997. Investigations on health-related properties of two sepiolite samples. Environ. Health Perspect. 105 (Suppl. 5), 1049-1052.
19. Biradar, S., Dhumal, R., Shah, M., Paradkar, A., Yamamura, S., 2009. Preparation of multiparticulate vaginal tablet using glyceryl monooleate for sustained progesterone delivery. Pharm. Dev. Technol. 14 (1), 38-49.
20. Braun, D.B. (Ed.), 1994. Over the Counter Pharmaceutical Formulations. Noyes Publications, New Jersey.
21. British Pharmacopoeia, 2009. London, The Stationery Office. http://www.pharmacopoeia.co.uk/pdf/2009-index.pdf.
22. Canadian Centre for Occupational Health and Safety (web page): http://search.ccinfoweb.ccohs. ca/ccohs/jsp/search/search.jsp?MaxDocs= 500&ResultStart=1&SortSpec=Score%2520desc&hi deTabs=F&hTab= 7&vTab=1&QueryText=sepiolite&ResultsCount=20.
23. Carretero, M.I., 2002. Clay Minerals and their beneficial effects upon human health. A review. Appl. Clay Sci. 21, 155-163.
24. Carretero, M.I., Gomes, C.S.F., Tateo, F., 2006. Clays and human health. In: Bergaya, F. et al., (Ed.), Handbook of Clay Science. Developments in Clay Science. Elsevier, Amsterdam, pp. 717-741.
25. Carretero, M.I., Lagaly, G., Showalter, M., 2007. Clays and health-clays in pharmacy, cosmetics, pelotherapy, and environment protection. Appl. Clay Sci. 36 (1-3), 1-200.
26. Castela, N., Keller, F., Benazeth, S., Souleau, C., 1998. Pharmaceutical compositions containing clays associated with cerium (III) ions for treating infections. Patent number: FR 2759692, 15 pp.
27. Cerezo, P., Iborra, C.V., López-Galindo, A., Ferrari, F., Caramella, C., 2001. Use of water uptake and capillary suction time measures for evaluation of the anti-diarrhoeic properties of fibrous clays. Appl. Clay Sci. 20, 81-86.
28. Changbing, Y., Jian, J., Shengying, X., Qinghua, Xu., 2008a. Toothpaste prepared from attapulgite clay, wild chrysanthemum and green tea, and its preparation method. Patent number: CN 101249053, 7 pp.
29. Changbing, Y., Jian, J., Shengying, X., Qinghua, Xu., 2008b. Toothpastes containing attapulgite clay and Flos. Patent number: CN 101234072, 7 pp.
30. Changbing, Y., Jian, J., Shengying, X., Qinghua, Xu., 2008c. Toothpastes containing attapulgite clay and Chrysanthemum for preventing gingivitis. Patent number: CN 101234075, 7 pp.
31. Changbing, Y., Jian, J., Shengying, X., Qinghua, Xu., 2008d. Toothpastes containing attapulgite clay and ginger. Patent number: CN 101234074, 7 pp.; Anticalculus toothpastes containing attapulgite clay and Chinese medicines for children. Patent number: CN 101234073, 7 pp.
32. Changbing, Y., Jian, J., Shengying, X., Qinghua, Xu., 2008e. Method for producing attapulgite clay/herb composite dentifrice. Patent number: CN 101229112, 7 pp.
33. Changbing, Y., Jian, J., Shengying, X., Qinghua, Xu., 2008f. Method for producing attapulgite clay/herb composite toothpaste. Patent number: CN 101229111, 8 pp.
34. Comparative Toxicogenomics Database (web page): http://ctd.mdibl.org/voc. go;jsessionid =E3030A3BBB2E7037243DAF4112A1B506?voc=chem&termUI= magnesium+trisilicate.
35. Cornejo, J., 1990. Las arcillas en formulaciones farmacéuticas. In: Galán, E., Ortega, M. (Eds.), Conferencias de la IX y X Reuniones de la Sociedad Española de Arcillas, SEA (Madrid), pp. 51-68.
36. Cornejo, J., Hermosin, M.C., White, J.L., Peck, G.E., Hem, S.L., 1980. Oxidative degradation of hydrocortisone in the presence of attapnlgite. J. Pharm. Sci. 69, 945-948.
37. Daabis, N.A., Naggar, V.F., Khalil, S.A., Motawi, M.M., 1976. The effect of some additives on the adsorption of tetracycline hydrochloride on magnesium trisilicate and milk. Pharmazie 31 (2), 125-129.
38. De Lapparent, J., 1936. The relation of the sepiolite-attapulgite series of phyllitic silicates of the mica type. Compt. Rend. 203, 482-484.
39. Derbyshire, E., 2005. Natural aerosolic mineral dusts and human health. In: Selinus, O. et al., (Ed.), Essentials of Medical Geology. Impacts of the Natural Environment on Public Health. Elsevier, Academic Press, San Diego, California, pp. 459-480.
40. DuPont, H.L., Ericsson, C.D., DuPont, M.W., Cruz, A., Mathewson, J.J., 1990. A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. Am. J. Med. 88 (6A), 20-23.
41. Elmore, A.R., 2003. Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. Int. J. Toxicol. 22 (Suppl. 1), 37-102.
42. EP 6.0, 2008. European Pharmacopoeia. Council of Europe-European Directorate for the Quality of Medicines.
43. Eriksson, U., Engström, G., Rigdahl, M., 1990. Viscosity of some clay based coating colors at high shear rates. Rheol. Acta 29, 352-359.
44. European Commission, Decision 96/335/EC. Inventory of ingredients used in cosmetic products, alphabetic by INCI name. Available at: http://europa.eu.int/ comm/enterprise/cosmetics/inci/incialf.htm.
45. Fadat, G., Engström, G., Rigdahl, M., 1988. The effect of dissolved polymers on the rheological properties of coating colours. Rheol. Acta 27, 289-297.
46. Fan, Y., Qinghua, X., Shengying, X., 2009a. Foam-free attapulgite -containing depilatory paste and its production process. Patent number: CN 101375832, 7 pp.
47. Fan, Y., Qinghua, X., Shengying, X., 2009b. Attapulgite foamless depilatory paste for animals and production method thereof. Patent number: CN 101375828, 6 pp.
48. Fang, J., 1988. Powder pharmaceuticals containing attapulgite for treatment of chronic ulcer in the lower extremities. Patent number: CN 86105579, 3 pp.
49. Farmer, S., Lefkowitz, A.R., 2005. Pharmaceutical and dietary compositions containing Bacillus bacteria and GI tract enzymes and anti-gas agents and anti-diarrheal agent for treatment of irritable bowel syndrome by increasing carbohydrate absorption. Patent number: US 2005100535, 12 pp.
50. FDA, 2003. Antidiarrheal drug products for over-the-counter human use. Final monograph. Fed. Regist. 68 (74), 18869-18882.
51. FDA, 2008. Active ingredients. In: FDA Approved Animal Drug Products, ("Green Book"). Section 2. FDA and Drug Information Laboratory publishers, Virginia Tech., USA.
52. FDA, 2009. Inactive Ingredients database for approved drug products. FDA/Center for Drug Evaluation and Research. Office of Generic Drugs. Division of Labeling and Program Support. http://www.fda.gov/Drugs/InformationOnDrugs/ Database Last Updated: July 10, 2009.
53. Fritz, A., Riehl, J., 1989. Stabilization of suspensions by simultaneous addition of polymers and peptizing salts. Pharm. Ind. 51 (10), 1150-1156.
54. Fulayyeh, I.Y.M., McBride, R.J., Murray, J.B., Qawas, A., Smith, G., 1981. Adsorption of antibacterial substances on attapulgite and light kaolin. J. Pharm. Pharmacol. (S1), p. 110 P.
55. Galan, E., Carretero, M.I., 1999. A new approach to compositional limits for sepiolite and palygorskite. Clays Clay Miner. 47 (4), 399-409.
56. Galán, E., Liso, M.J., Forteza, M., 1985. Minerales utilizados en la industria farmacéutica. Bol. Soc. Esp. Miner. 8, 369-378.
57. Gokhale, A., Bhalla, H.L., 1981. The in vitro uptake of chlorpheniramine maleate and betamethasone sodium phosphate by antacids. Indian J. Pharm. Sci. 43 (5), 162-165.
58. González-Pérez, M., Ubeda, C., Díez, I., 2009. Pharmaceutical formulations containing irbesartan. Patent number US 2009136571, 6 pp.
59. Governa, M., Valentino, M., Visonà, I., Monaco, F., Amati, M., Scancarello, G., et al., 1995. In vitro biological effects of clay minerals advised as substitutes for asbestos. Cell Biol. Toxicol. 11, 237-249.
60. Guthrie, G.D., 1992. Biological effects of inhaled minerals. Am. Mineral. 77 (3-4), 225-243.
61. Harrington, J.S., 1981. Fiber carcinogenesis: epidemiological observations and the Stanton hypothesis. J. Nat. Cancer Inst. 67, 977-989.
62. Hermosin, M.C., Cornejo, J., White, J.L., Hem, S., 1981. Sepiolite, a potential excipient for drugs subject to oxidative degradation. J. Pharm. Sci. 70 (2), 189-192.
63. Hoyo del, C., Vicente, M.A., Rives, V., 1998. Application of phenyl alicylate sepiolite systems as ultraviolet-radiation filters. Clay Miner. 38, 467-474.
64. Hu, Y., Wang, H., Tong, C., 2006. Attapulgite solid and liquid preparation for cure of digestive tract disease. Patent number: CN 1739575, 6 pp.
65. Huguet, H., Andremont, A., 2007. Site-specific intestinal delivery of adsorbents such as activated charcoal, clays, talc, silica, and resins, alone or in combination with degrading molecules used to adsorb any residual drug, metabolite thereof, or bacterial toxin after oral or parenteral drug administration. Patent number: WO 2007132022, 33 pp.
66. Hussain, F., Arayne, M.S., Sultana, N., 2006. Interactions between sparfloxacin and antacids-dissolution and adsorption studies. Pak. J. Pharm. Sci. 19 (1), 16-21.
67. IARC Summaries & Evaluation, 1997a. Palygorskite (Attapulgite). Monographs on the evaluation of carcinogenic risks to humans, vol. 68. IARC Scientific Publications, Lyon, France p. 245.
68. IARC Summaries & Evaluation, 1997b. Sepiolite. Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 68. IARC Scientific publications, Lyon, France, p. 267.
69. IARC Summaries & Evaluation, 1997c. Silica. Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 68. IARC Scientific publications, Lyon, France, p. 41.
70. Iwuagwu, M.A., Agidi, A.A., 2000. The effect of bleaching on the disintegrant properties of maize starch. STP Pharm. Sci. 10 (2), 143-147.
71. Iwuagwu, M.A., Aloko, K.S., 1992. Adsorption of paracetamol and chloroquine phosphate by some antacids. J. Pharm. Pharmacol. 44, 655-658.
72. Iwuagwu, M.A., Jideonwo, A., 1990. Preliminary investigations into the in vitro interaction of folic acid with magnesium trisilicate and edible clay. Int. J. Pharm. 65, 63-67.
73. Jaurand, M.C., Fleury, J., Monchaux, G., Nebut, M., Bignon, J., 1987. Pleural carcinogenic potency of mineral fibers asbestos attapulgite and their cytotoxicity in cultured cells. J. Natl. Cancer Inst. 79, 797-804.
74. Jian, J., Changbing, Y., Shengying, X., Qinghua, X., 2008a. Method for production of attapulgite and green tea toothpaste. Patent number: CN 101249051, 7 pp.
75. Jian, J., Changbing, Y., Shengying, X., Qinghua, X., 2008b. Method for producing attapulgite clay and Zanthoxylum nitidum composite toothpastes. Patent number: CN 101234076, 7 pp.
76. Jian, J., Changbing, Y., Shengying, X., Qinghua, X., 2008c. Toothpaste containing attapulgite clay and Chinese herbal medicines. Patent number: CN 101224180, 7 pp.
77. Jian, J., Changbing, Y., Shengying, X., Qinghua, X., 2008d. Dentifrice containing attapulgite clay and herbal ingredients for eliminating halitosis and preventing gingival bleeding. Patent number: CN 101224179, 7 pp.
78. Jian, J., Changbing, Y., Shengying, X., Qinghua, X., 2008e. Method for production of toothpaste containing black attapulgite and chinese herbal medicines. Patent number: CN 101224178, 7 pp.
79. Jian, J., Changbing, Y., Shengying, X., Qinghua, X., 2008f. Dentifrice powders containing attapulgite clay and Chinese herbal medicines. Patent number: CN 101224181, 7 pp.
80. Jian, J., Qinghua, X., Shengying, Xu., 2009a. Hair shampoo containing attapulgite clay and green tea and its production. Patent number: CN 101352401, 11 pp.
81. Jian, J., Qinghua, X., Shengying, Xu., 2009b. Attapulgite aloe shampoo. Patent number: CN 101342132, 9 pp.
82. Jian, J., Qinghua, X., Shengying, Xu., 2009c. Hair shampoos containing attapulgite clay and Chinese medicines Polygonum and others. Patent number: CN 101342134, 11 pp.
83. Jian, J., Qinghua, X., Shengying, Xu., 2009d. Attapulgite lycii conditioning shampoo. Patent number: CN 101342124, 9 pp.
84. Jian, J., Qinghua, X., Shengying, Xu., 2009e. Attapulgite and juglans regia composite conditioning shampoo. Patent number: CN 101342133, 11 pp.
85. Jovanovic, M., Samardzic, Z., Djuric, Z., Zajic, L., 1988. Effect of formulation on antacid value of magnesium trisilicate tablets. Acta Pharm. Hung. 58 (5), 215-220.
86. Karavas, E., Koutris, E., Ioannidou, E., Samara, V., Bikiaris, D., 2008. Solid dosage forms containing an HMG-CoA reductase inhibitor such as atorvastatin or fluvastatin in combination with colloidal clay such as attapulgite, and method for the preparation thereof. Patent number: WO 2009000286, 20 pp.
87. Khalil, S.A.H., 1974. Bioavailability of digoxin in presence of antacids. J. Pharm. Sci. 63, 1641-1643.
88. Khalil, S.A.H., Mortada, L.M., El-Khawas, M., 1984. Uptake of ampicillin and amoxicillin by some adsorbents. Int. J. Pharm. 18, 157-167.
89. Khalil, S.A.H., Mortada, L.M., Shams-El-Deen, M.A., 1987. Effect of attapulgite on the bioavailability of a model low dose drug (riboflavine) in humans. Drug Dev. Ind. Pharm. 13, 369-382.
90. Kostyniak, P., Giese, R., 2003. Novel pharmaceutical formulation to limit or delay surface absorption. Patent number: US 2003161866, 29 pp.
91. Lippmann, M., 1988. Asbestos exposure indices. Environ. Res. 46, 86-106.
92. Liu, B., Wang, J., 2008. Antibacterial agent containing nanoparticles of silver-loading attapulgite clay. Patent number: CN 101300981, 9 pp.
93. López-Galindo, A., Sánchez-Navas, A., 1989. Criterios morfológicos, cristalográficos y geoquímicos de diferenciación entre sepiolitas de origen sedimentario e hidrotermal. Bol. Soc. Esp. Miner. 12, 375-384.
94. López-Galindo, A., Viseras, C., 2004. Pharmaceutical and cosmetic applications of clays. In: Wypych, F., Satyanarayana, K.G. (Eds.), Clay Surfaces: Fundamentals and Applications. Elsevier, Amsterdam, pp. 267-289.
95. López-Galindo, A., Viseras, C., Cerezo, P., 2007. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Appl. Clay Sci. 36, 51-63.
96. Mascolo, N., Summa, V., Tateo, F., 1999. Characterization of toxic elements in clays for human healing use. Appl. Clay Sci. 15, 491-500.
97. Mascolo, N., Summa, V., Tateo, F., 2004. In vivo experimental data on the mobility of hazardous chemical elements from clays. Appl. Clay Sci. 25, 23-28.
98. Mathew, P., Naresh, T., Rasik, P., Vinayak, P., 2009. Pharmaceutical composition comprising a disintegration matrix. Patent number: CA 2644179, 33 pp.
99. Matlaga, B.R., Shah, O.D., Assimos, D.G., 2003. Drug-induced urinary calculi. Rev. Urol. 5 (4), 227-231.
100. McConnochie, K., Bevan, C., Newcombe, R.G., Lyons, J.P., Skidmore, W.J., Wagner, J.C., 1993. A study of Spanish sepiolite workers. Thorax 48, 370-374.
101. McElnay, J.C., D'Arcy, P.F., Leonard, J.K., 1982a. The effect of activated dimethicone, other antacid constituents, and kaolin on the absorption of propranolol. Experientia 38 (5), 605-607.
102. McElnay, J.C., Mukhtar, H.A., D'Arcy, P.F., Temple, D.J., Collier, P.S., 1982b. The effect of magnesium trisilicate and kaolin on the in vivo absorption of chloroquine. J. Trop. Med. Hyg. 85 (4), 159-163.
103. Mewis, J., Macosko, C.W., 1994. Suspension rheology. In: Macosko, C.W. (Ed.), Rheology: Principles, Measurements and Applications. VCH Pub, New York, pp. 425-474.
104. Mohamed, M.S., Ghazy, F.S., Abu-Zaid, S.S., El-Ghamry, H.A., 1989. In vitro adsorption studies of mebeverine hydrochloride. Mansoura J. Pharm. Sci. 6 (1), 37-52.
105. Moustafa, M.A., Gouda, M.W., Tariq, M., 1986. Decreased bioavailability of propranolol due to interactions with adsorbent antacids and antidiarroeal mixtures. Int. J. Pharm. 30, 225-228.
106. Moustafa, M.A., Al-Shora, H.I., Gaber, M., Gouda, M.W., 1987a. Decreased bioavailability of quinidine sulfate due to interactions with adsorbent antacids and antidiarrheal mixtures. Int. J. Pharm. 34 (3), 207-211.
107. Moustafa, M.A., Babhair, S.A., Kouta, H.I., 1987b. Decreased bioavailability of some antipsychotic phenothiazines due to interactions with adsorbent antacid and antidiarrheal mixtures. Int. J. Pharm. 36 (2-3), 185-189.
108. Muller, A.J., Kline, P.R., 1964. Topical therapeutic composition. US Patent no: 3137, 622 (june 16).
109. Naggar, V.F.B., 1985. In vitro interaction of antacids and antidiarrheals with allopurinol and probenicid. Indian J. Pharm. Sci. 47, 151-153.
110. Namburi, R.R., Vattikuti, B.M.K., Mulamalla, R.P., Palkhiwala, B.F., 2008. Physically stable aqueous suspensions of active pharmaceuticals. Patent number: US 2008260837, 9 pp.
111. Nikitakis, J.M., McEwen Jr., G.N. (Eds.), 1990. CTFA Compendium of Cosmetic Ingredient Composition-Specifications, Cosmetic, Toiletry and Fragrance Association, Washington, DC.
112. Nolan, R.P., Langer, A.M., Herson, G.B., 1991. Characterisation of palygorskite specimens from different geological locales for health hazard evaluation. Br. J. Ind. Med. 48 (7), 463-475.
113. Nunes, J., Melo, D., de Moura, M., de Farias, R., 2007. A Tg-Dsc study of binary mixtures of ascorbic acid with magnesium stearate, magnesium trisilicate and silicon dioxide: a contribution to pharmaceutical formulations. Mens Agitat 2 (2), 9-14.
114. Ofoefule, S.I., Okonta, M., 1999. Adsorption studies of ciprofloxacin: evaluation of magnesium trisilicate, kaolin and starch as alternatives for the management of ciprofloxacin poisoning. Boll. Chim. Farm. 138, 239-242.
115. Ogbeide, D.O., 1987. Study of a new formulation of diapec capsules in adults with acute diarrhea. Curr. Ther. Res. 41, 95-98.
116. Ohta, S., Nagai, K., Maruyama, M., Inoue, H., Katsuyama, Y., Atobe, O., et al., 1999. Preparation and characteristics of antibacterial sepiolite containing povidone-iodine as a useful pharmaceutical product for patient care. Biol. Pharm. Bull. 22 (1), 42-47.
117. Okor, R., Fajuyigbe, O., Eichie, F., 2004. Ampicillin adsorption by some antacids. Sci. Pharm. 72 (4), 309-316.
118. Onyeji, C.O., Babalola, C.P., 1993. The effect of magnesium trisilicate on proguanil absorption. Int. J. Pharm. 100, 249-252.
119. Ozdemir, O., Baktir, G., Ekinci, A.C., 1986. In vitro adsorption of hyoscine-N-butyl bromide by different antacids. Acta Pharm. Turc. 28 (3), 83-86.
120. Parkhomenko, V.V., Tretinik, V.Y., Kudra, L.A., 1987. Influence of electrolytes on structure formation in Palygorskite dispersions. J. Appl. Chem. 60, 2048-2052.
121. Post, J.L., Crawdord, S., 2006. Varied forms of palygorskite and sepiolite from different geologic systems. Appl. Clay Sci. 36, 232-244.
122. Qawas, A., Fulayyeh, I.Y.M., Lyall, J., Murray, J.B., Smith, G., 1986. Adsorption of bactericides by solids and the fitting of adsorption data to the langmuir equation by a nonlinear leastsquares method. Pharm. Acta Helv. 61, 314-319.
123. Qinghua, X., 2006a. Preparation and application of traditional Chinese medicinal composition comprising attapulgite clay. Patent number: CN 1850028, 8 pp.
124. Qinghua, X., 2006b. Black compound powder comprising attapulgite clay and traditional Chinese medicine for mud bath. Patent number: CN 1850027, 9 pp.
125. Qinghua, X., 2006c. Compound powder comprising attapulgite clay and traditional Chinese medicine for mud bath. Patent number: CN 1850026, 8 pp.
126. Qinghua, X., Jian, J., Shengying, Xu., 2009a. Attapulgite angelica shampoo. Faming Patent number: CN 101342128.
127. Qinghua, X., Jian, J., Shengying, Xu., 2009b. Hair shampoo containing attapulgite clays and black sesame. Patent number: CN 101342136, 11 pp.
128. Qinghua, X., Jian, J., Shengying, Xu., 2009c. Attapulgite and laminaria japonica composite shampoo and production method thereof. Patent number: CN 101342139, 10 pp.
129. Qinghua, X., Jian, J., Shengying, Xu., 2009d. Attapulgite and mint composite conditioning shampoo and production method thereof. Patent number: CN 101342129, 9 pp.
130. Qinghua, X., Jian, J., Shengying, Xu., 2009e. Attapulgite and chinese herbal medicine composite scurf-dispelling and alopecia-preventing shampoo. Patent number: CN 101342127, 9 pp.
131. Qinghua, X., Jian, J., Shengying, Xu., 2009f. Attapulgite dandruff-removing shampoo. Patent number: CN 101342126, 8 pp.
132. Ross, M., Nolan, R.P., Langer, A.M., Cooper, W.C., 1993. Health effects of mineral dusts other than asbestos. In: Guthrie, G.D., Mossman, B.T. (Eds.), Health Effects of Mineral Dusts. Reviews in Mineralogy, vol. 28. Mineralogical Society of America, Washington, DC, pp. 361-407.
133. Rowe, R.C., Sheskey, P.J., Weller, P.J. (Eds.), 2006. Handbook of Pharmaceutical Excipients. fifth ed. Pharmaceutical Press and the American Pharmaceutical Association, London, Chicago.
134. Russel, W.B., Saville, D.A., Schowalter, W.R., 1995. Colloidal Dispersions. Cambridge University Press, Cambridge, 525 pp.
135. Said, S.A., Abdullah, M.E., 1981. Effect of antacids on activity of oral hypoglycemics. J. Pharm. Sci. 70 (6), 621-624.
136. Santarén, J., Alvarez, A., 1994. Assessment of the health effects of mineral dusts. The sepiolite case. Ind. Miner. April, 101-117.
137. Shah, M., Biradar, S.V., Paradkar, A., 2006. Spray dried-magnesium trisilicate dry powder as cubic phase precursor. Int. J. Pharm. 323 (1-2), 18-26.
138. Shengying, X., Qinghua, X., 2006. Skin-moisturizing facial mask powder comprising attapulgite and traditional Chinese medicine. Patent number: CN 1850031, 10 pp.
139. Shenoy, D., Lee, R., Soppimath, K., Betageri, G., 2008. Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions comprising adsorbent carrier. Patent number: WO 2008063910, 33 pp.
140. Shifang, C., Shengying, X., Qinghua, X., 2008a. Attapulgite water based agent for preventing and treating mild chilblain. Patent number: CN 101284125, 7 pp.
141. Shifang, C., Shengying, X., Qinghua, X., 2008b. Ointment containing attapulgite clay and Chinese medicine alcohol extracts for preventing and treating chilblain and its preparation. Patent number: CN 101284126, 7 pp.
142. Shifang, C., Shengying, X., Qinghua, X., 2008c. Chinese medicinal composition containing attapulgite clay and Capsicum and others for preventing and treating frostbite. Patent number: CN 101284124, 7 pp.
143. Shifang, C., Shengying, X., Qinghua, X., 2008d. Method for preparing attapulgite pulicidal powder. Patent number: CN 101284104, 6 pp.
144. Shifang, C., Shengying, X., Qinghua, X., 2008e. Attapulgite pediculicide ointment and the preparation thereof. Patent number: CN 101284103, 7 pp.
145. Shifang, C., Shengying, X., Qinghua, X., 2008f. Attapulgite alcohol-based lousicide. Patent number: CN 101279064, 7 pp.
146. Shifang, C., Shengying, X., Qinghua, X., 2008g. Attapulgite water-based lousicide and its preparation process. Patent number: CN 101279065, 7 pp.
147. Sorby, D.L., 1965. Effect of adsorbents on drug absorption. I. Modification of promazine absorption by activated attapulgite and activated charcoal. J. Pharm. Sci. 54, 677-683.
148. Sorby, D.L., Liu, G., 1966. Effect of adsorbents on drug absorption. II. Effect of antidiarrhea mixture on promazine absorption. J. Pharm. Sci. 55, 504-510.
149. Stanton, M.F., Layard, M., Tegeris, A., Miller, E., May, M., Morgan, E., et al., 1981. Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J. Natl. Cancer Inst. 67, 965-975.
150. Sweetman, S. (Ed.), 2007. Martindale: The Complete Drug Reference. Pharmaceutical Press, London Electronic version (Available at: http://www.medicinescomplete.com/mc/martindale/current/).
151. Tateo, F., Summa, V., Bonelli, C.G., Bentivenga, G., 2001. Mineralogy and geochemistry of herbalist's clays for internal use: simulation of the digestive process. Appl. Clay Sci. 20, 97-109.
152. Tella, A.C., Owalude, S.O., 2007. Some Langmuir and Freundlich parameters of adsorption studies of chlorpheniramine maleate. Res. J. Appl. Sci. 2 (8), 875-878.
153. Thona, K., Lieb, H., 1983. Adsorption of drug substances by antacids and adsorbents and influence on bioavailability. Dtsch. Apoth. ZtG. 123, 2309-2316.
154. Tindal, A., Mangassi, O., 2008. Depilatory composition. PCT Int. Appl. WO 2008110745, 20 pp.
155. Torres-Ruiz, J., López-Galindo, A., Gonzalez, M., Delgado, A., 1994. Geochemistry of Spanish sepiolite-palygorskite deposits: genetic considerations based on trace elements and isotopes. Chem. Geol. 112, 221-245.
156. Torres-Ruíz, J., López-Galindo, A., González- López, J.M., Delgado, A., 1992. Spanish fibrous clays: an approach to their geochemistry and micromorphology. In: López-Galindo, A., Rodríguez-García, M.I. (Eds.), Electron Microscopy, Materials Sciences, vol. 2. Secretariado de Publicaciones, Universidad de Granada, pp. 595-596.
157. Ueda, H., Hamayoshi, M., 1992. Sepiolite as a deodorant material: an ESR study of its properties. J. Mater. Sci. 27, 4997-5002.
158. Uhlen, S., Toursel, F., Gottrand, F., 2004. Traitement des diarrhées aiguës: les habitudes de prescription des pédiatres libéraux. Arch. Pédiatr. 11, 902-907.
159. USP 32-NF 27, 2009. US Pharmacopoeial Convention, Rockville, MD, USA.
160. Vatier, J., Harman, A., Castela, N., Droy-Lefaix, M.T., Farinotti, R., 1994. Interactions of cimetidine and ranitidine with aluminumcontaining antacids and a clay-containing gastric-protective drug in an "artificial stomach-duodenum" model. J. Pharm. Sci. 83 (7), 962-966.
161. Viseras, C., López-Galindo, A., 1999. Pharmaceutical applications of some Spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies. Appl. Clay Sci. 14, 69-82.
162. Viseras, C., López-Galindo, A., 2000. Characteristics of pharmaceutical grade phyllosilicate powders. Pharm. Dev. Technol. 5 (1), 47-52.
163. Viseras, C., Meeten, G.H., López-Galindo, A., 1999. Pharmaceutical grade phyllosilicate dispersions: the influence of shear history on floc structure. Int. J. Pharm. 182, 7-20.
164. Viseras, C., Yebra, A., López-Galindo, A., 2000. Characteristics of pharmaceutical grade phyllosilicate compacts. Pharm. Dev. Technol. 5 (1), 53-58.
165. Viseras, C., Ferrari, F., Yebra, A., Rossi, S., Caramella, C., López-Galindo, A., 2001a. Disintegrant efficiency of special phyllosilicates: smectite, palygorskite, sepiolite. STP Pharm. Sci. 11 (2), 137-143.
166. Viseras, C., Cerezo, P., Meeten, G.H., López-Galindo, A., 2001b. One-dimensional filtration of pharmaceutical grade phyllosilicate dispersions. Int. J. Pharm. 217, 201-213.
167. Viseras, C., Aguzzi, C., Cerezo, P., López-Galindo, A., 2007. Uses of clay minerals in semisolid health care products. Appl. Clay Sci. 36, 37-50.
168. Wagner, J.C., Griffiths, D.M., Munday, D.E., 1987. Experimental studies with palygorskite dusts. Br. J. Ind. Med. 44, 749-763.
169. Wenninger, J.A., Canterbery, R.C., McEwen Jr., G.N. (Eds.), 2000. International Cosmetic Ingredient Dictionary and Handbook, vols. 1-3, eighth ed. Washington, DC, CTFA.
170. Yendamuri, S., Khatavkar, U.N., Aga, H.S., Malaviya, N., Deo, K.D., 2009. Meenakshisunderam, Sivakumaran. Controlled release dosage form of galantamine. Patent number: WO 2009024858, 24 pp.
171. Zhang, J., Feng, D., Yin, S., Cao, F., Gao, F., Li, M., 2004. Pharmaceutical composition for treating diarrhea containing superfine attapulgite and antibacterial. Patent number: CN 1476873.
172. Zhang, M., Li, S., Zhang, W., Xu, D., 2009. Application of attapulgite to prepare the medical preparations for treating chronic renal failure. Patent number: CN 101347453, 6 pp.